Zobrazeno 1 - 10
of 22
pro vyhledávání: '"van Hunsel FPAM"'
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 163. Bohn Stafleu van Loghum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::44eeb57ff637f997e72dcf16a0e6ae36
https://pure.eur.nl/en/publications/4942ee4b-5045-48e8-a615-b9442103e911
https://pure.eur.nl/en/publications/4942ee4b-5045-48e8-a615-b9442103e911
Autor:
Jajou R; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., Lieber T; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., van Puijenbroek EP; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands; Department of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, Netherlands., Mulder E; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., Overbeek J; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands., Hek K; Nivel (Netherlands Institute for Health Services Research), Utrecht, Netherlands., van Hunsel FPAM; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands; Department of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, Netherlands., Kant A; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands. Electronic address: a.kant@lareb.nl.
Publikováno v:
Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126130. Date of Electronic Publication: 2024 Aug 23.
Autor:
Woerdenbag HJ; Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands., Ursidae M; Pharmacy Master Programme, School of Science and Engineering, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands., Ekhart C; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands., Schmidt M; Department of Molecular Pharmacology, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands., Vitalone A; Department of Physiology and Pharmacology 'Vittorio Erspamer', Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy., van Hunsel FPAM; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands.; Department of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2024 Nov 06; Vol. 17 (11). Date of Electronic Publication: 2024 Nov 06.
Autor:
van den Bemt PMLA; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, Groningen, The Netherlands., van Puijenbroek EP; Science and Engineering, University of Groningen, Groningen, The Netherlands.; Netherlands Pharmacovigilance Centre Lareb, s-Hertogenbosch, The Netherlands., van Hunsel FPAM; Science and Engineering, University of Groningen, Groningen, The Netherlands.; Netherlands Pharmacovigilance Centre Lareb, s-Hertogenbosch, The Netherlands.
Publikováno v:
Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Jul; Vol. 23 (7), pp. 793-796. Date of Electronic Publication: 2024 Jul 03.
Autor:
Dontje AEWK; Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands., Schuiling-Veninga CCM; Department of Pharmacotherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands., van Hunsel FPAM; Department of Pharmacotherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvalei 7, 5237 MH 's-Hertogenbosch, The Netherlands., Ekhart C; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvalei 7, 5237 MH 's-Hertogenbosch, The Netherlands., Demirci F; Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, 26470 Eskisehir, Türkiye., Woerdenbag HJ; Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2024 Apr 29; Vol. 17 (5). Date of Electronic Publication: 2024 Apr 29.
Autor:
van Rijt-Weetink YRJ; Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, s-Hertogenbosch, The Netherlands.; Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands., Egberts TCG; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands., van Hunsel FPAM; Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, s-Hertogenbosch, The Netherlands.; Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands., Lewis DJ; Global Drug Development, Novartis Pharma GmbH, Wehr, Germany.; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK., Yates LM; University of Kwazulu-Natal, KRISP, Durban, South Africa.; Northern Genetics Service, Newcastle-upon-Tyne, UK., Winterfeld U; Swiss Teratogen Information Service and Clinical Pharmacology Service, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland., van Puijenbroek EP; Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, s-Hertogenbosch, The Netherlands. e.vanpuijenbroek@lareb.nl.; Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands. e.vanpuijenbroek@lareb.nl.
Publikováno v:
Drug safety [Drug Saf] 2024 Mar; Vol. 47 (3), pp. 261-270. Date of Electronic Publication: 2024 Jan 06.
Autor:
Ouaddouh C; Vaccine Team, Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., Duijster JW; Vaccine Team, Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., Lieber T; Vaccine Team, Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., van Hunsel FPAM; Vaccine Team, Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands.; Faculty of Science and Engineering, FarmacoTherapie, Epidemiologie en Economie Groningen Research Institute of Pharmacy, Groningen, the Netherlands.
Publikováno v:
Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Mar; Vol. 23 (3), pp. 323-331. Date of Electronic Publication: 2023 Oct 11.
Autor:
Slingerland P; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands., van Hunsel FPAM; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands. f.vanhunsel@lareb.nl., Lieber T; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands., van Balveren L; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands., Duijster JW; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands.
Publikováno v:
Drug safety [Drug Saf] 2023 Dec; Vol. 46 (12), pp. 1323-1334. Date of Electronic Publication: 2023 Oct 26.
Autor:
Tjeerdsma AM; Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands., van Hunsel FPAM; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands.; Department of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands., van de Koppel S; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands., Ekhart C; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, The Netherlands., Vitalone A; Department of Physiology and Pharmacology 'Vittorio Erspamer', Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy., Woerdenbag HJ; Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Aug 10; Vol. 16 (8). Date of Electronic Publication: 2023 Aug 10.
Autor:
van der Boom MDX; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., van Eekeren R; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., van Hunsel FPAM; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2023 Jul; Vol. 32 (7), pp. 783-794. Date of Electronic Publication: 2023 Mar 21.